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ABSTRACT
Characterization of small non-coding ribonucleic
acids (sRNA) among the large volume of data
generated by high-throughput RNA-seq or tiling
microarray analyses remains a challenge. Thus,
there is still a need for accurate in silico prediction
methods to identify sRNAs within a given bacterial
species. After years of effort, dedicated software
were developed based on comparative genomic
analyses or mathematical/statistical models.
Although these genomic analyses enabled sRNAs
in intergenic regions to be efficiently identified,
they all failed to predict antisense sRNA genes
(asRNA), i.e. RNA genes located on the DNA strand
complementary to that which encodes the protein.
The statistical models enabled any genomic region
to be analyzed theorically but not efficiently. We
present a new model for in silico identification of
sRNA and asRNA candidates within an entire bac-
terial genome. This model was successfully used to
analyze the Gram-negative Escherichia coli and
Gram-positive Streptococcus agalactiae. In both
bacteria, numerous asRNAs are transcribed from
the complementary strand of genes located in
pathogenicity islands, strongly suggesting that
these asRNAs are regulators of the virulence ex-
pression. In particular, we characterized an asRNA
that acted as an enhancer-like regulator of the type
1 fimbriae production involved in the virulence of
extra-intestinal pathogenic E. coli.
INTRODUCTION
The number of metabolic pathways in eubacteria known
to be controlled by regulatory small RNAs (sRNAs) is
growing. These pathways often regulate gene expression
post-transcriptionally by modulating mRNA translation
and/or mRNA stability through antisense mechanisms
involving base pairing interactions with dedicated
mRNA targets (1). Mechanistic studies revealed that
sRNAs also modulate protein activity by sequestering
them to modify their structures (2) or control the quality
of the protein synthesis (3). Most of the characterized bac-
terial sRNA genes have been found in the intergenic
regions (IGRs) of the core genome; in mobile genetic
elements, such as insertion sequences, plasmids and
phages (4); or in pathogenicity islands (PAI) (5,6).
Previous studies have shown that sRNAs can regulate
both bacterial metabolism as well as pathogenicity (7).
Recent data from high-throughput sequencing of the
transcriptome (RNA-seq) and tiling microarray analyses
have demonstrated the expression of many complemen-
tary sRNA/mRNA transcript pairs in Listeria mono-
cytogenes (8), Helicobacter pylori (9) and Escherichia coli
(10). These results highlight that the number of sRNA
genes located at the same genomic locus as protein
coding genes (CDS), but on the DNA opposite strand,
was underestimated. The sRNA molecules encoded by
these genes are referred to antisense RNAs (asRNA) or
naturally occurring RNAs. It was deduced from these
studies that the diversity of sRNAs is likely to be much
greater than expected, most particularly for asRNA genes,
which in turn raises a plethora of questions about their
functions (11). Few recent studies have indicated that
asRNA genes encoding molecules that are partially (12)
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al role but the contribution of asRNAs to regulation of
metabolism and pathogenicity has not been studied exten-
sively. RNA-seq and tiling microarrays represent signiﬁ-
cant technical advances for the identiﬁcation of sRNAs
because the whole transcriptome could be analyzed.
However, both techniques have strong limitations, par-
ticularly in terms of experimental costs and the cumber-
some nature of the data analysis and experimental
procedure, which includes the crucial choice of relevant
strains and growth conditions. Thus, in silico methods
remain of great interest for screening of a large number
of genomes without high cost and time consuming tasks.
Many methods for in silico identiﬁcation of sRNAs
exist, but only a few algorithms can efﬁciently predict
sRNA gene loci in the full bacterial genome sequence
(14). Different in silico methods based on comparative
genomics (15–19), statistics/probability analyses (20–24),
and RNA secondary structure analyses (16,25) have been
developed but they vary considerably in efﬁcacy. The most
recent algorithms for identiﬁcation of sRNA genes are
combinations of several pre-existing independent
methods, for increasing their sensitivity and predictive po-
tentials. However, most of these sRNA gene ﬁnders were
ﬁrst designed for and mainly applied to Gram-negative
bacteria and they require signiﬁcant adjustments to
analyze genomes of unrelated bacteria. Most of the
methods based on comparative genomics to identify
small (<500nt) conserved gene structures, including
promoter sequences, were highly bacterial order depend-
ent (15). Indeed, transcription promoters are highly
diversiﬁed and DNA recognition consensus sequences
among bacterial species were often divergent or not
known. Only Rho-independent terminators (RITs) identi-
ﬁcation seemed to be a valuable search for building an
almost general sRNA gene ﬁnder and can constitute the
basis of a gene signature research algorithm. Restriction of
the computational searches for novel sRNA genes located
in the IGRs constitutes another important limitation of
the current algorithms. Studies using machine learning al-
gorithms [i.e. stochastic context free grammar (16), neural
networks (20), boosted genetic programming (22), gapped
Markov model (23) and support vector machine (24)
methods] enabled the detection of new sRNAs in
protein-coding regions but the number of putative
asRNAs identiﬁed are variable between studies and
some of these studies lacked of in vivo validation.
Comparison of the data obtained by the application of
these mathematical models with those recently obtained
by RNA-seq or tilling microarray analyses demonstrated
that the efﬁciencies of these in silico analyses need im-
provements. The defect of these methods to identify
most asRNAs partially or fully overlapping protein-
coding genes, probably related to their low efﬁciency to
discriminate sequence conservations due to the presence of
a protein coding sequence from conservations due to the
presence of an asRNA gene. While these strategies are
interesting, their limitations are inherent to RNA sec-
ondary structure diversities that impaired the efﬁciency
of the co-variance model, especially for unstructured
sRNAs (16). Despite all efforts made, current methods
could be perfected and a number of strategies remain to
be tested.
We report here the development and validation of a new
in silico strategy, that successfully identiﬁes known and
new sRNA genes based on the analysis of the complete
genome sequence of Gram-negative and Gram-positive
bacteria, including those located in intergenic and CDS
regions. Improvement of current RIT searches and covari-
ation identiﬁcation by our new algorithms enhanced
sRNAs discovery. For example, analysis of the genomes
of extra-intestinal pathogenic E. coli (ExPEC) and
Streptococcus agalactiae, two opportunistic pathogens in
which gene regulation undoubtly plays an important role
in pathogenesis, led to the identiﬁcation of numerous
new sRNAs, including asRNA genes speciﬁc for the
ExPEC strains or the Group B Streptococci. Transcription
analysis of sRNAs located close to pathogenicity-
associated gene clusters and functional characterization
of two asRNAs suggested that they might control the ex-
pression of pathogenicity-related genes in both bacteria
which conﬁrmed the efﬁciency of our new method.
MATERIALS AND METHODS
Genome and pathogenicity island sequences
All genome sequences of E. coli and S. agalactiae were
obtained from the Genbank database (http://www.ncbi
.nlm.nih.gov/genbank/). The PAI-IAL862 of E. coli AL862
strain was sequenced at the Pasteur Institute and was de-
posited to Genbank under accession number GQ497943.
Identiﬁcation of RITs
For Gram-negative bacteria, RITs were predicted with the
RNAMotif program (26) by a slightly modiﬁed version of
the previously described method (27). We used the perfect
stem loop structure template as described, except that we
permitted no more than one mismatch within the stem
structure. We also used the same scoring formula, excepted
that the G
0
37 of the RNA:DNA hybrid duplex of the
poly-uracil tail and its complementary genomic sequence
were scored with Melting4 software, using nearest
neighbor thermodynamic parameters (28). All candidates
with a score greater than  4.0kcal/mol were removed.
For Gram-positive bacteria, Rho-independent terminators
were predicted by TransTermHP (29).
Bacterial strains and growth conditions
All E. coli strains (Table 1) were cultured in Luria Bertani
(LB) or M9 supplemented with 0.4% of sodium pyruvate
media. S. agalactiae NEM316 was grown in Todd Hewitt
(TH) or RPMI1640 medium supplemented with 0.4%
glucose and 5% 1M HEPES buffer. Antibiotics for
plasmid selection were used at the following concen-
trations: for E. coli, carbenicillin, 100mg/ml, kanamy-
cin, 50mg/ml, and chloramphenicol, 12.5mg/ml; for
S. agalactiae, erythromycin, 5mg/ml. The 536 hfq::
KmFRT strain was constructed by the allelic exchange re-
combination protocol using the thermosensitive plasmid
pKOBEG-Apra (36). The 500 nucleotides adjacent to
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assembled with the kanamycin FRT ﬂanked cassette
from the pKD4 plasmid by PCR prior to strain transform-
ation (38).
RNA sample preparation
All cultures were established with a 1/50 dilution of an
overnight culture, incubated at 37 C under shaking at
140rpm. Samples were prepared from cultures stopped
during the exponential phase of growth OD600 of 0.6 for
E. coli or OD600 of 0.4 for S. agalactiae, or stationary
phase after 24h for both bacteria. Total RNAs was
isolated from E. coli strains with Trizol (Invitrogen),
used according to the manufacturer’s protocol except
that the bacteria were harvested by centrifugation at
4000g for 5min at room temperature, to prevent cold
shock stress. Total RNAs was extracted from S. agalactiae
with hot phenol as described (Pichon 2005 5). RNA
samples were treated twice, with 30 units of DNase I
(Amersham) for 90min at 37 C and extracted by
phenol/chloroform treatment and precipitated in ethanol.
The RNA was re-suspended in DEPC-treated water and
checked for putative degradations on 2% agarose gel.
Genomic DNA contaminations were analyzed by PCR
ampliﬁcation of the 5S RNA using the 5S.Fw and
5S.RT primers.
RACE experiments
The determination of the 50-end of sRNAs were done as
previously described (39).
Nested and classic RT–PCR
Chimeric DNAs (cDNA) were synthesized from 5mgo f
heat-denatured total RNAs with 200 units of Superscript
III reverse transcriptase enzyme (Invitrogen). For analyses
of sRNA expression, the reaction was performed at 55 C
for 1h with 2pmol of gene speciﬁc primer (Sigma Proligo)
(Supplementary Table S1) to maintain stringent condi-
tions and synthesized strand speciﬁc products. For
mRNA expression analysis, the reaction was performed
at 42 C for 1h with 200ng of random hexamer according
to supplier’s protocol. Reactions were inactivated by
Table 1. Strains and plasmids used in this study
Name Description Genotype/Resistance
a Reference
Strains
E. coli AL862 Sepsis-associated ExPEC isolate afa8
+ (30)
E. coli 536 Pyelonephritis-associated ExPEC isolate (O6:K15:H31) pap
+, ﬁm
+ (31)
E. coli 536 ﬁm::cat Deletion of the full ﬁm gene cluster Cm
R (32)
E. coli 536 hfq::KmFRT Allelic exchange of the hfq gene with kanamycin FRT cassette Km
R This study
S. agalactiae NEM316 Human septicaemia isolate (33)
E. coli TOP10 Laboratory strain ﬁm
- (34)
E. coli TOP10hfq::KmFRT Hfq-deﬁcient strain JVS-2001 Km
R (34)
E. coli TOP10hfq::FRT Hfq-deﬁcient strain JVS-2001 with the FRT ﬂanked kanamycin
resistance cassette removed by action of the FLP ﬂipase
from pCP20 plasmid
Km
S This study
Plasmids
pCP20 Thermosensitive plasmid expressing the ﬂp ﬂippase gene Cb
R, Cm
R (35)
pKOBEG-Apra Thermosensitive recombination plasmid used for allelic
exchange
pSC101
ts, Apra
R (36)
pZE21-gfp gfp gene under the control of the PLtetO-1 promoter ColE1, Km
R (37)
pZE2R-gfp Replacement of the PLtetO-1 promoter from pZE21-gfp by the
P  constitutive promoter
ColE1, Km
R (37)
pZE21-null pZE1-gfp derivative expressing a non sense sRNA ColE1, Km
R This study
pZE2R-null pZE2R-gfp derivative expressing a non sense sRNA ColE1, Km
R This study
pZE2R-ﬁmR Insertion of ﬁmR gene into the EcoRI/XbaI sites of the
pZE2R-gfp plasmid
ColE1, Km
R This study
pZE21-antiﬁmR Insertion of ﬁmR antisense sequence into the EcoRI/XbaI
sites of the pZE21-gfp plasmid
ColE1, Km
R This study
pZE2R-SQ18 Insertion of SQ18 gene into the EcoRI/XbaI sites of the
pZE2R-gfp plasmid
ColE1, Km
R This study
pXG-0 Luciferase-expressing plasmid pSC101*, Cm
R (34)
pXG-10 Translational fusion of lacZ and gfp genes pSC101*, Cm
R (34)
pXGﬁmD::gfp pXG10 derivative with a ﬁmD::gfp translational fusion pSC101*, Cm
R This study
pXGgbs0031::gfp pXG10 derivative with a gbs0031::gfp translational fusion pSC101*, Cm
R This study
pTCV-erm-VPtet Shuttle low-copy vector to analyze regulatory elements in
Gram-positive bacteria under the control of the constitutive
promoter Ptet
pAMb1, Erm
R S. Dramsi
pTCV-SQ18 Insertion of the SQ18 sRNA gene into the BamHI/PstI sites
of pTCVerm-Ptet plasmid.
pAMb1, Erm
R This study
pTCV-SQ485 Insertion of the SQ485 sRNA gene into the BamHI/PstI sites
of pTCVerm-Ptet plasmid.
pAMb1, Erm
R This study
pTCV-SQ893 Insertion of the SQ893 sRNA gene into the BamHI/PstI sites
of pTCVerm-Ptet plasmid.
pAMb1, Erm
R This study
aApra, Cb, Cm, Erm, Km were resistance to apramycin, carbenicillin, chloramphenicol, erythromycin and kanamycin, respectively.
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PCR done with 0.4 units of Taq polymerase (QBiogen),
100nM of each primer pair (gene.RT and gene.Fw or
gene.Nested and gene.Fw for nested PCR), 200mM
dNTP and 2ml of the RT reaction. The thermal cycling
were 94 C, 3min, followed by 40 cycles of 94 C, 30s;
55 C, 30s; and 72 C for 30s. and ﬁnal extension of
72 C, 7min. PCR products were analyzed by electrophor-
esis in 4% ethidium bromide-stained agarose gels.
Northern blot hybridization
Northern blot membranes were prepared and hybridiza-
tion was carried out as described (5). Brieﬂy, RNA
samples were separated by urea denaturating polyacryl-
amide gel electrophoresis and transferred to Zeta probe
GT membranes (Biorad). Membranes were hybridized
with
32P5 0-end-labeled oligonucleotides in ExpressHyb
(Clontech) and scanned with a PharosFX system (Biorad).
Analysis of small RNA and mRNA interaction
The pZE2R-null and pZE21-null plasmids were con-
structed by digesting the pZE2R-gfp and pZE21-gfp
plasmids with EcoRI (Invitrogen) and XbaI (Roche).
The DNA fragments containing the kanamycin resistance
gene and the origin of replication were separated by gel
electrophoresis and extracted from the agarose with the
Qiagen gel extraction kit. We treated 200ng of the two
cleaved plasmid DNA fragments with Klenow enzyme
(NEB) for 1h at room temperature, followed by
re-circularization with T4 DNA ligase (Fermentas) and
transformed in the TOP10 strain.
For expression of the FimR and SQ18 sRNAs in E. coli,
we ampliﬁed the ﬁmR gene from E. coli 536 and the SQ18
gene from S. agalactiae NEM316 genomic DNAs by PCR
using Taq DNA polymerase (MPbio) with cl.ﬁmR.EcoRI
and cl.ﬁmR.XbaI or cl.SQ18.EcoRI and cl.SQ18.XbaI
primers, respectively. The two PCR products were
inserted to pCRII-TOPO plasmid (Invitrogen). The
pCRII-ﬁmR or pCRII-SQ18 plasmids were digested with
EcoRI and XbaI. The DNA band containing the sRNA
gene was puriﬁed from the gel and ligated with pZE2R
DNA digested with EcoRI and XbaI, with T4 DNA
ligase. The ligation products were transformed in the
TOP10 strain, generating the pZE2R-ﬁmR and pZE2R-
SQ18 plasmids. The pZE21-antiﬁmR plasmid was con-
structed in the same way as pZE2R-ﬁmR, except that we
used the cl.antiﬁmR.EcoRI and cl.antiﬁmR.XbaI primers
for PCR.
The ﬁmD::gfp and gbs0031::gfp fusion genes were ex-
pressed by inserted the ﬁmD and gbs0031 CDSs depleted
of stop codons into the pXG10 plasmid as described (34).
The DNA fragments containing the ﬁmD and gbs0031
CDSs were ampliﬁed with LA Taq (Takara) with
ﬁmD.NheI and ﬁmD.Mph1103I or gbs0031.NheI and
gbs0031.Mph1103I primers, respectively. The other steps
and Western blotting were done as described (34).
For expression of the SQ18, SQ485, SQ893 sRNAs in
S. agalactiae, we ampliﬁed the three sRNA genes from
S. agalactiae NEM316 genomic DNAs by PCR using
Taq DNA polymerase (MPbio) with cl.SQ18.BamHI
and cl.SQ18.PstI or cl.SQ485.BamHI and cl.SQ485.PstI
or cl.SQ893.BamHI and cl.SQ893.PstI couple of primers,
respectively. The PCR products were ﬁrst cloned into the
pCRII-TOPO plasmid (Invitrogen) and recloned into
the BamHI/PstI sites of the shuttle vector pTCV-erm-
VPtet plasmid, giving the pTCV-SQ18, pTCV-SQ485,
pTCV-SQ893 expression plasmids. These vectors were
introduced by electroporation in S. agalactiae NEM316.
Analysis of expression by quantitative real-time PCR
Total RNAs were reverse-transcribed as described in the
section on RT–PCR, except that 10mg of total RNA were
used. All primers were designed with Primer3 (http://
www-genome.wi.mit.edu/cgi-bin/primer/primer3_www
.cgi). We determined mRNA and 5S RNA levels from
cDNAs synthesized with random primers. The sRNA
levels were analyzed with cDNAs synthesized with
speciﬁc primers. All cDNA samples were analyzed using
iQ SYBR green supermix (BioRad) according to manu-
facturer protocol and were run on a MyiQ thermal cycler
(BioRad) with the following thermal cycling conditions,
95 C 5min, 40 cycles of 95 C, 30s; 60 C for 60s. All ex-
periments were carried out with at least two duplicate
RNA samples. The 5S rRNA was used as reference and
the gene and relative level of expression between samples
were calculated by the Ct method (40).
Yeast agglutination, motility and bioﬁlm assays
All assays were carried out with E. coli strains cultured in
LB broth and incubated overnight at 37 C without
shaking. The culture medium was eliminated by centrifu-
gation and bacteria were washed once with 1X PBS. Yeast
agglutination assays and motility tests were performed as
described (41). Bioﬁlm formation assays were conducted
in polypropylene microtiter plates. Bacteria were grown
statically in LB and M63 glucose media for 48h, and
bioﬁlms were visualized by crystal violet staining as
described (42).
RESULTS
Design and validation of an sRNA geneﬁnder based on
the identiﬁcation of orphan RITs
We hypothesized that the core prediction system for
a versatile sRNA geneﬁnder algorithm that predicted
preferentially non-coding sRNAs should combine several
functionalities. First, it should predict the signatures
composed of recognition sites for sRNA-binding
proteins, for example RIT. Second, it should be able to
inspect the ﬂanking nucleic acid sequences using com-
parative genomic and RNA structure predictions plus a
scoring method based on covariation analysis, to provide
a strong phylogenetic evidence for the existence of RNA
stems (2,14).
The RIT site, which is often involved in the termination
processes of sRNA genes in E. coli ( 70%) and in other
bacteria such as Staphylococcus aureus (5), was used as a
starting point for our sRNA search model (Figure 1). By
applying it to the genome of the extensively studied E. coli
Nucleic Acids Research,2012, Vol.40, No. 7 2849MG1655, we detected 16 959 putative terminators with a
G
0
37  4kcal/mol score. The 1504 RIT located close to
the stop codon (from  25 to +60nt) on the same DNA
strand as a CDS were automatically removed from the
data set. The remaining putative terminators and the
200-nt upstream sequences were considered as sRNA can-
didate signatures. Their sequence conservation was
analyzed using FASTA 3.4 software (43) against 44
complete genomes of Enterobacteria (Genbank database,
24/07/2007). Insigniﬁcant hits with an e-value >0.0001
were excluded. MASR software was used to transform
FASTA pairwise alignments into multi-alignment. RNA
structure predictions of sRNA signature candidates were
done with the Mfold 3.2 program (44). The CSSR
program, by combining MASR multiple alignments and
Mfold predictions, detects the RNA structure conserva-
tions and presence of covariations (see supplementary
data for a description of MASR and CSSRTo identify
the most probable sRNA genes, candidates were ranked
according to their RIT scores (Supplementary Table S2).
Our model identiﬁed sRNA candidates associated with
an RIT within CDSs. However, the large number of can-
didates identiﬁed in E. coli MG1655 (>2000 antisense
and >3000 sense sRNA candidates) suggested that these
included high number of false-positives. We therefore
ﬁltered-out sense and antisense candidates in which
the G 
37 score of the RIT was less that  8kcal/mol.
Finally, we scored sRNA candidates from E. coli
MG1655 on the basis of their RIT, which were weighted
by the number of covariation pairs found by CSSR.
Threshold values of  4kcal/mol or  8kcal/mol for the
RIT score and a requirement for at least two covariations,
including one in the RIT stem, led to the prediction of
1867 sRNA candidates that could be classiﬁed into eight
different groups according to their position relative to
adjacent CDSs (Table 2). In order to maximize the predic-
tion of non-coding sRNAs, small CDSs were tentatively
predicted using Glimmer2 software (45).
Efﬁciency of the in silico model
We ﬁrst tested whether the use of covariations efﬁciently
selected true positive sRNAs and rejected true negative
candidates by using our in silico model to analyze the
101 known sRNAs from the E. coli MG1655 strain
(Supplementary Table S4), which included 18 asRNAs.
All the sRNA sequences were submitted directly to
the core software by bypassing the RIT predictions
(Figure 1B). The core software identiﬁed 77 (92.7%) of
the sRNAs located in the IGR and 16 (88.9%) of the
asRNAs as putative candidates. The statistical signiﬁcance
of the covariation identiﬁed by the Covation Search in
Small RNAs software (CSSR) was evaluated by shufﬂing
the 101 sRNA multi-alignments using the Altschul and
Erikson shufﬂe algorithm (25). In these conditions, the
total number of covariations found by CSSR in sRNAs
was 73.7% lower than for the unshufﬂed data set, suggest-
ing that most of the predicted covariations were statistic-
ally signiﬁcant.
We assessed the efﬁciency of our in silico model as an
sRNA geneﬁnder by its ability to re-predict known bona
ﬁde sRNAs with RIT in six complete genome sequences
(Table 3). Globally, our in silico model detected
known sRNAs with efﬁciencies of 70.1% and 71.3% for
IGR-located sRNAs and asRNAs, respectively. In the
case of E. coli MG1655, among the sRNAs with a RIT
that were not identiﬁed, rybB and rydC genes have a RIT
with a loop size that exceeds the maximum length
tolerated by our method. Other candidates among those
not identiﬁed the rdlA, rdlC, sokA, sokC, sokE and sokX
were all cis-regulatory sRNAs. We suggested that putative
structural constraints were applied to these sRNAs
leading to the use of atypical RIT. The E. coli MG1655
strain transcriptome was recently analyzed in an RNA-seq
experiment and 5 out of the 10 newly conﬁrmed sRNAs
were re-predicted by our in silico analysis (47). Conﬁrmed
sRNAs from published RNA-seq analysis of S. aureus
N315 were compared to our data and 62.5% of the
transcribed sRNAs (with and without RIT) were
re-predicted (48). Given that our in silico model was able
to predict candidates irrespective of their expression, we
were able to re-identify four known sRNAs (RNAIII,
Sau-02, Sau-30, RsaE) that were absent from RNA-seq
data (48).
Figure 1. UML activity diagram for our in silico sRNA prediction
model. (A) The ﬁrst part of this process involves the prediction of
sRNA protein-binding sites (RIT prediction in this study) and extrac-
tion of the ﬂanking sequences. (B) Core software for sRNA analysis
and discovery based on a combination of comparative genomics, RNA
prediction and covariation analysis.
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isolates
Escherichia coli is a species encompassing a broad variety
of commensal and pathogenic strains that have diverged
due to a high rate of genetic exchange (49). Using an ex-
haustive and hand-curated database of sRNA genes found
in the genera Escherichia, we recently updated the anno-
tation of known sRNAs in the genome of the MG1655
strain (Supplementary Table S4). We also reported that
these genes were structurally well conserved in the genome
of 6 pathogenic and commensal strains recently
sequenced, although their copy number may vary (49).
These data suggested that unidentiﬁed sRNAs that are
absent from the MG1655 strain might be involved in regu-
latory pathways speciﬁc to pathogenic isolates.
We thus focused our searches for sRNAs on ExPEC
strains, a group of major human pathogens responsible
for urinary tract infections, meningitis, sepsis, etc. (50).
Despite extensive studies, no gene or pool of genes specif-
ically linked to extra-intestinal virulence has been
identiﬁed in these strains. This strongly suggests that
virulence results from multi-factorial processes depending
on the expression of both core-genome and strain-speciﬁc
genes (49). We thus investigated the possible role of
ExPEC speciﬁc sRNAs in virulence control by applying
our in silico model to the entire genomes of three clinical
isolates (UTI89, 536 and S88) which are associated with
cystitis, pyelonephritis and newborn meningitis, respect-
ively (49,51,52). We also analyzed the sequence of the
tRNA
Phe inserted PAI from AL862 strain (PAI-IAL862),
a sepsis isolate (30).
The RIT-associated sRNA candidates from the whole
genomes or PAI-IAL862 sequences were collected with our
model and classiﬁed according to their genomic coordin-
ates (Supplementary Table S3), as summarized in Table 2.
In each genome, we identiﬁed more than 1500 sRNA can-
didate genes. The number of putative sRNA genes located
in the IGRs did not exceed 200 ( 10% of all candidates),
a ﬁnding consistent with other in silico searches (19). Most
of these candidate genes were located in the core genome
( 81.8% on average) rather than in PAIs (data not
shown) suggesting that they may regulate the general cell
Table 2. Summary of sRNA candidates identiﬁed in silico
Strain Disease IGR asRNA 50 asRNA 30 asRNA 50 &3 0 asRNA 50 UTR 30 UTR sense RNA
Escherichia coli
MG1655 L. S. 195 452 74 142 73 89 199 643
UTI89 Cys. 199 398 66 95 77 96 170 527
536 Pyl. 191 388 66 107 54 73 140 496
AL862 Sep. 9 6 2 2 0 3 3 4
S88 Men. 212 430 63 103 85 90 154 532
Streptococcus agalactiae
NEM316 Sep. 41 63 12 24 6 5 21 25
IGR, intergenic region; asRNA, sRNA antisense to a CDS; 50 asRNA, antisense to the 50-end of a CDS; 30 asRNA, antisense to the 30-end of a
CDS; 50 UTR, 50 untranslated region of a CDS; 30 UTR, 30 untranslated region of a CDS. For classiﬁcation of the sRNA candidates into one of
these categories, the ﬁrst nucleotide of the RIT was used as the position reference of the candidate. This nucleotide had to be on the opposite DNA
strand, between nucleotides  50nt to+15nt around the ATG codon (50 asRNA), from position+15nt with respect to the ATG codon to position –
50nt near the stop codon (asRNA) or from –50nt to+15nt around the stop codon (30 asRNA). When candidates were on the same DNA strand as
the CDS, the window around the ﬁrst RIT nucleotide was<–100nt before the ATG codon (50 UTR),<+200nt after the stop codon (30 UTR) and
from+50nt after the ATG to –50nt before the stop codon (seRNA). All candidates outside a CDS not included in a previous category are referred
to IGR candidates. All candidates had to have a RIT with a score of G 
37<-4kcal/mol and at least two covariations had to be present in the RNA
structure including the stem of the RIT. For asRNA and seRNA candidates, G 
37 had to be below -8kcal/mol. L. S., laboratory strain; Cys.,
cystitis; Pyl., pyelonephritis; Sep., sepsis; Men., meningitis. Only the PAI-IAL862 sequence of the AL862 strain was analyzed.
Table 3. Efﬁciency of the in silico process for predicting previously known sRNAs in six bacterial species
Gram Strains Total known sRNAs sRNA genes in IGR asRNA genes in CDS
Known sRNA
with RIT
Success
(%)
Known asRNA
with RIT
a
Success
(%)
b
  E. coli MG1655 101 60 86.7 5 60
  S. typhimurium LT2 79 51 70.6 0 NA
  V. cholerae O1 40 31 90.4 9 55.5
  P. aeruginosa PAO1 24 24 66.7 0 NA
+ S. aureus N315 55 38 76.3 1 100
+ L. monocytogenes EGD-e 50 27 29.6 10 70
aThe RITs of the published asRNA genes were not characterized by authors.
The efﬁciency of sRNAs prediction was calculated from data for bona ﬁde sRNA genes. Only sRNAs that had been experimentally validated by
Northern blots, 50 RACE and RT–PCR were taken into account. We excluded unconﬁrmed sRNAs from RNA-seq or tiling microarray data and 50
or 30 UTRs from mRNAs.
bNA, Not Applicable.
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among sRNA candidates ( 40% of all candidates), par-
tially or fully antisense to a CDS, that were dispersed
throughout the genome sequences, including their PAIs
(data not shown). The partially asRNA candidates
( 15% of all candidates) overlaps either the upstream or
downstream regions of a CDS, suggesting that they
control the translation and/or stability of the complemen-
tary mRNA. In the case of the 59000bp PAI-IAL862
sequence, 29 sRNA gene candidates were predicted, 10
(34.5%) being asRNAs, a percentage similar to that
found in other ExPEC genomes. As shown for MG1655
analysis, many candidates were found in sense orientation
within CDSs ( 34% of all candidates).
Given the large number of sRNA candidates, we
focused on those genetically associated with clusters of
genes known to be involved in extra-intestinal virulence,
in particular the ExPEC-speciﬁc PAI-IAL862 (E. coli
AL862), PAI-II536 (E. coli 536) and the ﬁm gene cluster
encoding type 1 ﬁmbriae (E. coli 536). Screening by RT–
PCR analysis revealed that six out of the seven sRNA
candidates from PAI-IAL862 were transcribed: one candi-
date was located in an IGR and ﬁve were asRNAs
(Supplementary Figure S1A). We evaluated the sensitivity
of our RT–PCR method by carrying out hemi-nested
RT–PCR experiments (53) (Supplementary Figure S2A).
This analysis did not conﬁrm expression of the SQ24 and
SQ27 asRNAs, both targeting a putative transposase
CDSs (Supplementary Figure S2B). Expression and size
of the two of four remaining sRNAs was analyzed by
Northern blot due to their co-localization with pathogenic
factor genes (Figure 3A). The same transcription analysis
was carried out for 10 sRNA candidates from the genome
of the E. coli 536 strain, including nine candidates located
in PAI-II536 sequence and 1 in the ﬁm gene cluster: two
candidates were located in IGRs and 8 were asRNAs.
All candidates were expressed in our growth conditions
as shown by our expression screening by RT–PCR
(Supplementary Figure S1B) associated with hemi-nested
RT–PCR performed to conﬁrm the speciﬁcity of RT–PCR
reactions for all sRNAs (data not shown). Northern blot
analyses of several candidates were done to conﬁrm size
and expression of selected relevant sRNA (Figure 3B).
Comparative sequence analysis by our in silico model
showed that all but one of the 14 validated sRNAs of
E. coli AL862 and 536 were frequently found in the
genome of sequenced ExPEC isolates but not in other
E. coli pathotype strains. The remaining SQ8017 sRNA
was located in the ﬁm gene cluster encoding the
virulence-associate type 1 ﬁmbriae present in almost all
commensal and pathogenic strains. Most of the new
sRNA genes identiﬁed in this study are asRNAs genetic-
ally associated with a cluster of genes involved in ExPEC
pathogenicity which suggests that they may be involved in
virulence control (Table 4). Data for other expressed or
not tested candidates are shown in Supplementary Data.
The FimR asRNA from E. coli 536 up-regulates the
expression of type 1 ﬁmbriae
In E. coli, type 1 ﬁmbriae play a role in the development of
urinary tract infections by mediating adhesion to speciﬁc
receptors on the uroepithelium. During the pathogenesis
of cystitis, type 1 ﬁmbriae promote the invasion of bladder
cells and the formation of intra cellular communities (54)
but they are also involved in bioﬁlm formation (55). The
ﬁm gene cluster is composed of nine genes (Supplementary
Figure S4) whose expression is controlled by phase vari-
ation and various regulators. As SQ8017 asRNA and
ﬁmD CDS are located in the same genomic locus, we
hypothesized that this asRNA controlled the expression
of the ﬁm gene cluster and we therefore renamed it
FimR. Mapping of the transcription start site of ﬁmR by
50 RACE was determined at position T4852969 in the
sequence of the E. coli 536 strain (Table 4). Analysis of
ﬁmR promoter region revealed the presence of a putative
s
E promoter. The ‘AA’ tract from the -35 box, the in-
variable C-residue from the -10 box, the 17bp spacer,
the 6bp discriminator sequence and the -1 T-residue
were observed, indicating such prediction may be
reliable. Thus, it suggested that FimR expression is
controlled by environmental stimuli (56). Given the
position of ﬁmR promoter and RIT, the calculated RNA
size was  440nt compatible with the  410nt long RNA
observed by Northern blot (Figure 3).
Type 1 ﬁmbriae mediate adhesion to mannose-
containing receptors, a biological trait quantiﬁed in vitro
with the yeast agglutination assay (57,41). The speciﬁcity
of the assay for evaluating the expression of the ﬁm gene
cluster of E. coli 536 was conﬁrmed with a 536 ﬁm
Figure 2. Comparative analysis of sRNAs identiﬁed by our in silico model based on sequence conservation among ExPEC strains. Venn diagram
representations of the number of sRNA predicted in IGR (A) and of asRNAs predicted in CDSs (B).
2852 Nucleic Acids Research, 2012,Vol.40, No. 7mutant that does not agglutinate. We tested our hypoth-
esis by constructing derivatives of strain 536 over-
expressing FimR or a FimR antisense sRNA (antiFimR)
and assessing the yeast agglutination titer. The expression
of antiFimR should inactivate the FimR regulation
pathway by competing with FimR mRNA substrate.
The primary transcript of the ﬁmR gene including its
RIT was cloned under the control of the P  promoter of
pZE2R-gfp to give the pZE2R-ﬁmR plasmid. We also con-
structed pZE21-antiﬁmR by cloning in antisense the same
primary transcript under the control of the PLtetO-1
promoter. These ﬁmR, antiﬁmR and mock plasmids were
Figure 3. Northern blot analysis of some sRNAs from E. coli AL862, 536 and S. agalactiae NEM316 strains. Expression analysis of 7 sRNA
candidates co-localized with virulence factors (see Table 4) and identiﬁed in (A) E. coli AL862, (B) E. coli 536 and (C) S. agalactiae NEM316 strains.
Expression was analyzed in two phases of growth (E, exponential; S, late stationary) in LB and M9+0.4% pyruvate (M9py) media for E. coli or TH
and RPMI1640+0.4% glucose media for S. agalactiae. Expression of the constitutively transcribed 5S ribosomal gene was used as loading control.
The C0465 sRNA which is expressed only in early stationary phase in E. coli MG1655 strain was used as a negative expression control (46). Notes,
ig, sRNA gene located in the IGR; as, sRNA gene located a position antisense to a CDS (asRNA). Black arrows indicated hybridized sRNA
molecules.
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FimR and antiFimR over-expression in E. coli 536 sig-
niﬁcantly modiﬁed the agglutination titer (4-fold increase
and 4-fold decrease, respectively; Table 5). These ﬁndings
indicate that FimR upregulates the production of type 1
ﬁmbriae.
FimR asRNA binds the ﬁmD mRNA and positively
regulates type 1 ﬁmbriae expression
We assessed the putative base-pairing interaction of
FimR and ﬁmD mRNA using a translational control
and target recognition system (34). A translational
fusion of ﬁmD and gfp genes was constructed by fusing
the full stop-codon-less ﬁmD CDS to the ATG-less gfp
gene from pXG10 plasmid. Expression of the ﬁmD::gfp
fusion was monitored by quantitative RT–PCR and
Western blot in E. coli TOP10 (a ﬁm strain) harboring
pXGﬁmD::gfp target plasmid or pXG-0 (no target
control) and either pZE2R-ﬁmR or pZE2R-null plasmids
(Figure 4). Comparison of the relative levels of expression
of ﬁmD::gfp mRNA in pZE2R-ﬁmR and pZE2R-null
bearing strains showed that FimR over-expression was
associated with a 8-fold increase of the amount of fusion
mRNA (Figure 4A). Western blot experiments with
antibodies directed against the GFP protein revealed
a 2-fold increase in FimD::Gfp protein expression, con-
sistent with the transcriptome analysis (Figure 4A).
Accumulation of the ﬁmD::gfp and FimR transcripts
strongly suggested that these RNA molecules may be
stabilized when co-expressed (Figure 4A). A post-
transcriptional regulation of ﬁmD mRNA by FimR
likely occurs through a putative antisense base-pairing
between the two RNA molecules.
We investigated the role of FimR in vivo by carrying out
a more detailed analysis of expression of the ﬁmBE and
ﬁmAICDFGH operons and of FimR asRNA of E. coli 536
carrying pZE2R-ﬁmR, pZE21-antiﬁmR, or mock plasmids
by quantitative RT–PCR. Over-expression of FimR from
a multicopy plasmid ( 17 copies per chromosome equiva-
lent) increased 2.34-fold the expression of ﬁmB to H
(Figure 5A). This result suggests that FimR positively
regulates not only ﬁmD, but also of the entire ﬁm gene
Table 4. List of validated sRNA genes located close to virulence-related genes
Candidate sRNA Origin Loc.
a 50-end
b 30-end
c Type
d Target
genes
e
Target function O. g.
f ExPEC
speciﬁc?
g
Score
h N/
kcal/mol
Escherichia coli
SQ8164 IntP4R E. c. 536 PAI-II 4735462 4735232 asRNA intP4 PAI DNA mobility <> No 10/ 26.28
SQ7560 PrfR E. c. 536 PAI-II 4747389 4747630 asRNA prfF Adhesion >< Yes 3/ 12.64
SQ7575 HlyR E. c. 536 PAI-II 4763726 4763963 asRNA hlyA Hemolysis >< Yes 2/ 5.76
SQ7606 HaeR E. c. 536 PAI-II 4783731 4783731 asRNA ECP_4580 Filamentous
haemagglutinin
>< Yes 9/ 6.52
SQ8017 FimR E. c. 536 Core 4852969* 4852518 asRNA ﬁmD Adhesion <> No 15/ 8.49
SQ109 AfaR E. c. AL862 PAI-I 56564* 56332 IGR afa8 Adhesion >< Yes 2/ 5.2
SQ19 IntR E. c. AL862 PAI-I 58845 59076 asRNA Int PAI DNA mobility <> No 12/ 14.94
Streptococcus agalactiae
SQ18 SQ18 S. a. NEM316 Core 47857* 47734 asRNA gbs0031 Surface exposed protein >< N.A. 3/ 10
SQ340 SQ340 S. a. NEM316 PAI-X 1163702* 1163779 IGR gbs1118 Transposase of TnGBS2 >< N.A. 3/ 10.5
SQ893 SQ893 S. a. NEM316 Core 1300661 1300360 IGR gbs1263 Fibronectin binding protein <> N.A. 3/ 4
SQ407 SQ407 S. a. NEM316 PAI-XII 1350419 1350658 asRNA Lmb Laminin binding protein >< N.A. 11/ 11.5
SQ485 SQ485 S. a. NEM316 Core 1655610 1655852 asRNA gbs1588/
gbs1589
Putative ABC transporter >< N.A. 9/ 10.3
SQ1004 SQ1004 S. a. NEM316 PAI-XIII 2052153 2052383 IGR gbs1987 Streptomycin resistance >< N.A. 3/ 7.6
aLocalization of the sRNA gene. Core, core genome; PAI, pathogenicity islands.
bThe 50-end of the sRNA candidate is arbitrarily located 200bp upstream from the ﬁrst nucleotide of the predicted RIT. An asterisk indicates the 50
triphosphates RNA end determined by 50 RACE. The 50 ends of SQ109 (E. coli AL862) and SQ340 (S. agalactiae NEM316) sRNAs were determined
in another study (C.P., personal communication).
cThe 30-end of the sRNA candidate is deﬁned as the last nucleotide of the RIT poly-uracil tail.
dType of sRNA candidate gene locus. IGR, intergenic region; asRNA, sRNA antisense to a CDS.
eAntisense sRNA predicted target mRNA. The sRNA genes located in an IGR may regulate adjacent genes by an antisense mechanism.
fO. g., Orientation of genes (order sRNA/mRNA).
gSpeciﬁcity was determined by FASTA analysis against the Genbank database.
hN, number of covariations identiﬁed/RIT score in kcal/mol.
E.c., Escherichia coli; S.a., Streptococcus agalactiae
Table 5. Yeast agglutination assays for E. coli 536 derivatives
Strain Yeast agglutination
titer
536+pZE2R-null 1/16
536+pZE2R-ﬁmR 1/64
536 ﬁm::cat+pZE2R-null NO
536 ﬁm::cat+pZE2R-ﬁmR NO
536+pZE21-null 1/16
536+pZE21-antiﬁmR 1/4
536 ﬁm::cat+pZE21-null NO
536 ﬁm::cat+pZE21-antiﬁmR NO
536 1/16
536hfq::KmFRT NO
The level of expression of type 1 ﬁmbriae was assessed in E. coli 536
wild type and mutant strains expressing the FimR sRNA, the antiFimR
sRNA or mock plasmids. No 536 ﬁm strains agglutinated yeasts
indicating that the agglutination phenotypes resulted from the expres-
sion of type 1 ﬁmbriae. NO: not observable.
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relative expression level of ﬁm genes in strain 536 which
carries pZE21-antiﬁmR. The antiFimR over-expression
decreased 4.18-fold ﬁm expression to reach a value lower
than that obtained with mock plasmid (Figure 5B)
indicating that FimR inhibition down-regulated ﬁm gene
expression. Furthermore, yeast agglutination assays with
E. coli 536 + pZE2R-ﬁmR cultured in human urine for
24h showed that FimR increased the agglutination titer to
the levels found with bacteria grown in LB medium (data
not shown). It is thus likely that FimR controls type 1
mediated adhesion in vivo during host colonization.
Hfq is required for ﬁmD/FimR base pairing
About 40% of the known sRNAs from E. coli require
the Hfq protein to interact with their targets. Since Hfq
contributes to the virulence of the ExPEC E. coli UTI89
strain (57), we investigated the requirement of this protein
for FimR regulation in E. coli 536. We investigated the
requirement of Hfq protein for FimR/ﬁmD interaction by
introducing the pXGﬁmD::gfp or pXG-0 plasmids into
the TOP10 hfq::FRT strain harboring either pZE2R-
ﬁmR or pZE2R-null plasmids. In contrast to the vari-
ations in gene expression observed in TOP10 cells, quan-
titative expression analysis of ﬁmR and gfp genes in
TOP10 hfq::FRT revealed no signiﬁcant differences in
either the RNA or protein levels in the presence or
absence of FimR (Figure 4B). The loss of FimR-
dependent regulation indicated that the Hfq protein was
required for the binding of FimR to ﬁmD::gfp mRNA.
We investigated the role of Hfq in vivo by constructing
the E. coli 536 hfq::KmFRT strain and assessed adhesion
mediated by type 1 ﬁmbriae with a yeast agglutination
assay. As expected, loss of hfq expression induced the
loss of visible agglutination, suggesting that fewer type 1
ﬁmbriae were produced in the hfq
- mutant (Table 5). Next,
we assessed the relative expression levels of the ﬁmBE and
ﬁmAICDFGH operons and of FimR asRNA of E. coli 536
hfq::KmFRT by quantitative RT–PCR. As expected,
loss of hfq expression decreased of ﬁmBE and
ﬁmAICDFGH mRNA production by an average  4-fold
and that of FimR asRNA by  6-fold. The ﬁmA gene
encoding the major structural subunit of type 1 ﬁmbriae
( 1000 to 10000 monomers per ﬁmbriae) was impacted
more severely and decreased  7-fold. Taken together,
these results suggest that Hfq regulated type 1 ﬁmbriae
synthesis by mediating base pairing of FimR with ﬁmD
mRNA.
The FimR regulon controls bioﬁlm development
and bacterial motility
We checked whether the expression of ﬁm genes was
linked to FimR regulation and controlled virulence by
Figure 4. Over-expression of FimR and SQ18 antisense sRNAs regulates the ﬁmD and gbs0031 target genes, respectively. (A) Analysis by Western
blot and quantitative RT–PCR of gfp and FimR gene expression in E. coli strain TOP10 harboring pZE2R-ﬁmR or pZE2R-null plasmids combined
with pXG-0 (no gfp target control) or pXGﬁmD::gfp target expression plasmids. The four isolates were cultured in LB medium at 37 C until they
reached an OD600 of 0.9. Quantitative expression of the gfp fusion gene was normalized to 1.0 for the TOP10+pZE2R-null+pXGﬁmD::gfp strain.
FimR expression was normalized to 1.0 for the TOP10+pZE2R-ﬁmR+pXG-0 strain. (B) Western blot and quantitative RT–PCR analysis were
performed as described in (A) but in a hfq context. Asterisks indicate a signiﬁcant difference between mean values in unpaired t-tests (P<0.01).
Nucleic Acids Research,2012, Vol.40, No. 7 2855investigating various ﬁmbriae-associated phenotypes in
E. coli 536 expressing the ﬁmR and antiﬁmR genes.
The adhesion mediated by type 1 ﬁmbriae is an import-
ant factor in bioﬁlm formation (55). As FimR enhanced
type 1 ﬁmbriae production, we investigated the effect
of FimR on bioﬁlm formation for E. coli 536 deriva-
tives carrying pZE2R-ﬁmR, pZE21-antiﬁmR, or mock
plasmids. In our conditions, the strains that expressed
the pZE2R-ﬁmR or the mock plasmids displayed similar
levels of bioﬁlm formation whereas the E. coli 536+
pZE21-antiﬁmR isolate formed no detectable bioﬁlm
(data not shown). These observations suggest that FimR
is required for bioﬁlm development.
The productions of type 1 ﬁmbriae and ﬂagella have
been shown to be co-regulated in various pathogenic
E. coli isolates (55). We therefore analyzed the relation
between FimR and motility by performing motility tests
on various E. coli 536-derived strains. Compared to a null
plasmid-bearing strain, motility was unaffected by the
over-expression of FimR but signiﬁcantly decreased by
over-expression of antiFimR, resulting in virtually
non-motile bacteria (data not shown). Thus, under labora-
tory growth conditions, ﬁmR expression is linked to type 1
ﬁmbriae-mediated bioﬁlm formation, and bacterial
motility; two phenotypes known to be important in the
urovirulence of ExPEC strains.
Identiﬁcation of sRNAs from S. agalactiae
The Gram-positive bacterium S. agalactiae (also referred
to as Group B Streptocccus, GBS) is a major cause of
bacterial sepsis, pneumonia and meningitis in newborns
and is also responsible for pregnancy-related morbidity
(58). As our in silico model is based on the recognition
of RIT-associated signatures found in both Gram-
negative and Gram-positive bacteria, we assessed
whether our program was efﬁcient for predicting
asRNAs also in Gram-positive bacteria. We assessed its
efﬁciency by searching sRNAs in S. agalactiae strain
NEM316. All steps of the process were identical to those
used for E. coli except the following modiﬁcation:
TransTerm HP was used to predict RITs and comparative
genomics analyses were carried out with a database of
Lactobacillale genome sequences (Genbank release of
07/06/2008). The data collected from our in silico search
revealed the existence of 197 sRNA candidates with genes
located in the IGRs while others were partially or fully
antisense to CDSs (Table 2). In addition, some candidates
were located upstream or downstream from a CDS and
were putative mRNA encoded regulatory elements
(e.g. Riboswitch). Interestingly, as in the E. coli analysis,
sense RNA candidates were also predicted.
The genes of sRNA candidates were distributed
throughout the genome and we analyzed by RT–PCR
the expression of 30 out of 197 sRNA candidates
located both in the core genome and PAIs. The expression
of the TmRNA and 5S sRNA genes was used as positive
controls. The analysis revealed that 26 out of the 30 pre-
dicted sRNA candidates were expressed thus demonstrat-
ing the versatility and efﬁciency of our in silico model
(Supplementary Figure S1C).
To conﬁrm the RT–PCR results, we further
characterized by Northern blot analysis with
32P labeled
oligonucleotides the 26 RT–PCR positive sRNA candi-
dates. Ten candidates gave a strong hybridization signal.
The absence or weak signal obtained for the other candi-
dates may be due to lower sensitivity of the Northern blot
technique compared to RT–PCR (data not shown).
The SQ18, SQ485, SQ655 and SQ893 sRNAs gave
multiple bands suggesting a cleavage by ribonucleases
or a transcription initiated from multiple promoters
(Figure 3, Supplementary Figure S5). Four validated
sRNAs were found to be located close or antisense
to CDS involved in the pathogenicity of S. agalactiae
Figure 5. FimR sRNA up regulates type 1 ﬁmbriae gene expres-
sion in vivo. Quantitative real-time RT–PCR analysis of expression
of the ﬁmBEAICDFGH gene cluster was performed in (A) E. coli
536+pZE2R-ﬁmR relatively to E. coli 536+pZE2R-null, (B) E. coli
536+pZE21-antiﬁmR relatively to E. coli 536+pZE21-null and
(C) 536 hfq::KmFRT relatively to 536 strains, cultured in LB
medium statically at 37 C for 24h (stationary phase).
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indicated that none of the sRNAs described here were
present in sequenced strains of the phylogenetically
related pathogen Streptococcus pyogenes and that none
of the sRNAs previously described in S. pyogenes were
present in S. agalactiae, suggesting that these molecules
display a high degree of species speciﬁcity in the genus
Streptococcus. However, as recently reported, one of our
sRNA candidates (SQ517) has an ortholog (csRNA12) in
Streptococcus pneumoniae (59).
The SQ18, SQ485 and SQ893 sRNAs from S. agalactiae
NEM316 modulate expression of adjacent genes
As shown for the ExPEC strains, some sRNAs were found
to be near virulence-related gene clusters. So we
investigated whether the SQ18 and SQ485 asRNAs and
the SQ893 sRNA over-expression regulated the expression
of other genes in the S. agalactiae NEM316 strain. The
primary RNA transcripts of adjacent antisense genes to
SQ18, SQ485 and SQ893 sRNAs were determined by
searching in silico for putative promoters and terminators.
This analysis revealed that the adjacent mRNA transcripts
of gbs0031, gbs1588 and gbs1263 were putative antisense
targets of SQ18, SQ485 and SQ893 sRNAs, respectively.
To test these hypotheses, we cloned each of the three
sRNA genes downstream the strong promoter Ptet in
the shuttle vector pTCV-erm-VPtet, giving pTCV-SQ18,
pTCV-SQ485 and pTCV-SQ893 plasmids. These plasmids
were introduced into the S. agalactiae NEM316 strain and
the expression of the putative target genes was analyzed by
qRT–PCR (Figure 6A). Over-expression of the SQ18
asRNA and the SQ893 sRNAs signiﬁcantly decreased
the levels of their respective target mRNAs gbs0031 and
gbs1263, suggesting that both sRNAs act as negative regu-
lators. In contrast, over-expression of the SQ485 asRNA
led to an increase in the amount of gbs1588 mRNA, sug-
gesting that this asRNA acts as a positive regulator
(Figure 6A).
The SQ18 asRNA from S. agalactiae NEM316
down-regulates expression of the Sip gene by an
antisense mechanism
A translational control and target recognition system (34)
was used for investigating the putative base pairing
between SQ18 asRNA and gbs0031 mRNA which
encodes a surface immunogenic protein (Sip) that elicits
protective immunity against group B streptococci (60).
We ﬁrst characterized the 50-end of the primary transcript
of SQ18 by 50 RACE. The 50 triphosphate end was
determined at G47857 and was associated with a putative
s
A promoter (Table 4). The SQ18 gene was inserted into
pZE2R-gfp to give pZE2R-SQ18 and the stop-codon-less
gbs0031 CDS was fused to the ATG-less gfp gene from
pXG10, giving the pXGgbs0031::gfp plasmid. Four
TOP10 strains harboring pZE2R-SQ18 or pZE2R-null
plasmids combined with pXGgbs0031::gfp or pXG-0
plasmids were constructed. The expressions of the sRNA
and the fusion mRNA were analyzed by quantitative
RT–PCR and Western blot. Comparison of the relative
levels of expression of gbs0031::gfp mRNA in pZE2R-
SQ18 and pZE2R-null bearing strains showed that SQ18
over-expression was associated with a 4-fold decrease in
the amount of the fusion mRNA (Figure 6B). Con-
sistently, Western blot experiments carried out with
antibodies directed against GFP (Gbs0031::Gfp) indicated
a 2.6-fold decrease of the amount of Gfp fusion in the
strain over-expressing SQ18 (Figure 6B). Thus, SQ18 is
Figure 6. SQ18, SQ893 and SQ485 sRNAs controlled the gbs0031,
gbs1263 and gbs1588 target genes expression, respectively. (A) Quan-
titative real-time RT–PCR analysis of expression of gbs0031, gbs1263
and gbs1588 gene. The relative expression of the three mRNA genes
were determined by comparing over-expressing strains S. agalactiae
NEM316+pTCV-SQ18 or pTCV-SQ485 or pTCV-SQ893 against the
wild-type S. agalactiae NEM316 isolate. (B) Analysis by Western
blot and quantitative RT–PCR of the expression of the gfp and
SQ18 gene expression in E. coli TOP10 strain harboring pZE2R-
SQ18 or mock plasmids combined with pXG-0 (no gfp target
control) or pXGgbs0031::gfp expression plasmids. SQ18 expression
was normalized to 1.0 for the TOP10+pZE2R-SQ18+pXG-0 strain.
Asterisks indicate a signiﬁcant difference between mean values in
unpaired t tests (P<0.01).
Nucleic Acids Research,2012, Vol.40, No. 7 2857a negative post-transcriptional antisense regulator of
gbs0031::gfp gene activity when expressed in E. coli.
DISCUSSION
High-throughput sequencing of bacterial transcripts
(RNA-seq) or tilling microarray experiments showed
that sRNA gene diversity is far greater than expected
(8,9,61,62). In particular, these data revealed the existence
of mRNA and asRNA pairs transcribed from genes
present at the same locus, but on opposite DNA
strands. There is a growing interest in the analysis of bac-
terial sRNAs in particular their contribution to gene regu-
lation including the expression of virulence factors, but the
identiﬁcation of the full set of sRNA genes as performed
by RNA-seq or tiling microarray remains a difﬁcult task
and the experimental costs remain high. We have thus
designed and validated a new in silico model that efﬁ-
ciently identiﬁes sRNA genes, including asRNAs, in any
bacterial genomes, including both IGR and CDS regions.
Our analysis of genome sequences from ExPEC and
S. agalactiae, two major human pathogens, predicted the
existence of numerous sRNAs, including asRNAs
co-localized with virulence-associated genes.
Previous in silico methods for identifying de novo
sRNAs in bacterial genomes increased in efﬁciency over
time, but they are still limited for the analysis of IGR and
do not predict asRNAs that partially or totally overlap
neighboring CDS. Several sRNAs have been described in
E. coli and other species (1), but few data are available for
asRNAs (4,12,13). Our combination of RIT prediction,
comparative genomics, RNA structure prediction with
an implemented scoring system based on a RIT score
and the analysis of covariations, identiﬁed  1800 and
 200 sRNA candidates for E. coli and S. agalactiae
genomes, respectively. The mean efﬁciency of our in
silico model, based on the analysis of six genomes and
expressed as the percentage of predicted versus known
sRNAs, was estimated to be 70.1% and 71.5% for
sRNAs located in the IGR and asRNAs, respectively
(Table 3) which suggests that it is an efﬁcient tool for
analyzing any bacterial genomes. Up to now, few innova-
tive in silico models were able to identify asRNA genes.
The corresponding algorithms, based on comparative
genomic approaches or mathematical/statistical analyses
of the RNA secondary structures, were validated only
with E. coli genomes (20,23,24,25) and only a few
asRNA candidates were identiﬁed. In addition, these
tools were either unable to predict sRNA genes de novo
(25) or lacked validation data supporting their use as
reliable asRNAs ﬁnders (20,23,24). Our study suggests
that our in silico model can predict asRNA genes fully
transcribed from CDS regions in antisense and possibly
in sense orientation. Recent RNA-seq data suggested the
existence of sense sRNAs but no biological functions were
identiﬁed to date (9). Globally, we identiﬁed here sRNA
and asRNA candidates evenly distributed throughout
the genome. Based on the recognition efﬁciency of
known E. coli sRNAs (Table 3), our approach appears
as reliable as all currently available algorithms.
The main limitation of our approach is that it requires
RIT prediction to detect sRNAs. We initially used RIT
prediction to demonstrate that our in silico model efﬁ-
ciently identiﬁed known sRNAs in E. coli because
72.3% of known sRNA genes located in IGRs have an
RIT. As a consequence, sRNA genes that utilize atypical
RITs or a different termination process were not predicted
with our model. We had hypothesized that any protein
binding sites in sRNA could be the starting point of
our predictive model. Thus, identiﬁcation of the Rho
protein or the Hfq binding sites may be good alternatives
to enhance our sRNAs prediction model especially as
RNA-seq data for E. coli (10) and Salmonella species
(62) showed that RIT seemed to be less frequent in
asRNA genes (< 50%). On the other hand, we used
two distinct RIT prediction models, which might exhibit
variable predictive efﬁciencies for different bacteria.
This approach is also limited by the number of fully
sequenced genomes available and the requirement that
the genetic divergence among these sequences be
minimal to allow covariation identiﬁcation. During our
study, 15E. coli and 3 S. agalactiae sequences were avail-
able and the mutation frequency among the genomes
within these two species was not the same. The sequence
conservation among S. agalactiae strains was higher than
it was for the E. coli strains. Thus, the different RIT pre-
diction efﬁciencies obtained for these two bacteria may
explain why we identiﬁed ten times more candidates in
E. coli than S. agalactiae.
The Hfq protein is the chaperone for sRNAs found in
numerous bacterial species that is involved in the regula-
tion of general cell metabolism and virulence (1,2,7). It
has recently been shown that Hfq contributes to the viru-
lence of E. coli strains causing urinary tract infection,
a subgroup of the ExPEC pathotype suggesting that
sRNAs have an important regulatory role on the expres-
sion of ExPEC virulence (57). We analyzed multiple
genome sequences of ExPEC strains which revealed that
there is a set of sRNA genes speciﬁc to this pathotype.
Species-speciﬁc sRNAs have been identiﬁed in other
bacteria, such as S. aureus (5) or S. typhimurium (6), but
they are mostly located in IGR and their distribution
could not be often easily associated with a function and
a degree of virulence. In particular, this is the case for the
virulence associated sRNA genes like RNAIII (63) and
SprD from S. aureus (64) and FasX from S. pyogenes
(65). In contrast, the identiﬁcation of FimR, HlyR, and
PrfR asRNAs in clusters of genes required for the patho-
genesis of cystitis and pyelonephritis (50) suggested the
possible association of these asRNAs with these
pathologies as observed for the AmgR asRNA from
S. enterica (66). In contrast, the Hfq-dependent FimR
regulation constitutes a rare case of an asRNA acting as
a positive regulator of gene expression, thus revealing the
importance of this new asRNA function. However, the
molecular mechanisms by which FimR regulates type
1 ﬁmbriae production is still a matter of debate despite
the fact that it was extensively studied (11). Recent models
of the post-transcriptional activation of collagenase
mRNAs by VR-RNA in clostridia or of the
streptokinase mRNA by FasX in Group A Streptococci
2858 Nucleic Acids Research, 2012,Vol.40, No. 7(67) provides insight into some of the possible mechanism
of regulation by FimR asRNA.
The control of expression of virulence genes during
pathogenesis is critical for the opportunistic pathogen
S. agalactiae. As only three complete genome sequences
are currently available for the group B streptococci,
the distribution of sRNA genes in this species remains
largely unknown. We analyzed the genome sequence of
the virulent strain NEM316 and identiﬁed 197 sRNA/
asRNA genes and validated the expression of 26 of
them. One putative sRNAs previously reported to
interact with the CiaRH regulatory system from
S. agalactiae NEM316 has been also identiﬁed in our
analyses (59). Distribution of sRNA genes was uniform
along the S. agalactiae NEM316 genome including the
core genome and PAIs. Moreover, the location of sRNA
genes in the PAI of S. agalactiae suggest that this may be a
common feature in pathogenic bacteria as reported for
S. aureus (5) and S. typhimurium (6). These observations
indicated that pathogenesis of Group B Streptococci may
be controlled by sRNAs, as demonstrated in Group A
Streptococci (65,68,69). The regulatory roles of the
SQ18, SQ485 and SQ893 sRNAs on adjacent mRNAs
expression involved in virulence, as demonstrated in this
study, provide additional support to this hypothesis.
However, the role of sRNAs/asRNAs in the control of
the virulence of Group B Streptococci remains to be
characterized and our list of candidates may facilitate
these studies.
This report demonstrated that an sRNA gene ﬁnder
approach can efﬁciently identify sRNAs located within
IGRs, asRNAs and putative sense RNAs transcribed
within CDSs. The main advantage of in silico approaches
over in vivo techniques (tiling microarrays and RNA-seq)
is the capability to search for sRNAs in an unlimited
number of strains irrespective of their growing conditions.
This catalog may then be used to select the most valuable
strains for in vivo studies and should facilitate the
post-screening identiﬁcation of expressed sRNAs and
asRNAs in large collections of data. Accordingly, the
results of our analysis of the genomes of two major
human pathogens, E. coli and S. agalactiae, suggest that
sRNAs as well as asRNAs are key elements in the control
of their virulence.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables S1–S5, Supplementary Figures
S1–S5, Supplementary Materials and Supplementary
References [5,10,15,23,43,46,63,70–97].
ACKNOWLEDGEMENTS
We thank Shaynoor Dramsi for pTCV-erm-VPtet plasmid
gift, Ulrich Dobrindt for E. coli strains gift, Christophe
Beloin for pZE21-gfp and bioﬁlm analysis, Christiane
Bouchier for PAI-IAL862 sequencing and Jo ¨ rg Vogel for
the complete pXG plasmids system. We also thank
Carmen Buchreiser for critical reading of the article.
FUNDING
This work was supported by Institut Pasteur (PTR165 to
C.P.); Agence National de la Recherche for the ERA-NET
Pathogenomics project (ANR-06-PATHO-002-03);
Postdoctoral fellowship by the French Region Ile-de-
France (DIM Malinf to C.P.). Funding for open access
charge: Institut Pasteur.
Conﬂict of interest statement. None declared.
REFERENCES
1. Waters,L.S. and Storz,G. (2009) Regulatory RNAs in Bacteria.
Cell, 136, 615–628.
2. Pichon,C. and Felden,B. (2007) Proteins that interact with
bacterial small RNA regulators. FEMS Microbiol. Rev., 31,
614–625.
3. Gillet,R. and Felden,B. (2001) Emerging views on
tmRNA-mediated protein tagging and ribosome rescue.
Mol. Microbiol., 42, 879–885.
4. Brantl,S. (2007) Regulatory mechanisms employed by cis-encoded
antisense RNAs. Curr. Opin. Microbiol., 10, 102–109.
5. Pichon,C. and Felden,B. (2005) Small RNA genes expressed from
Staphylococcus aureus genomic and pathogenicity islands with
speciﬁc expression among pathogenic strains. Proc. Natl Acad.
Sci. USA, 102, 14249–14254.
6. Pfeiffer,V., Sittka,A., Tomer,R., Tedin,K., Brinkmann,V. and
Vogel,J. (2007) A small non-coding RNA of the invasion gene
island (SPI-1) represses outer membrane protein synthesis from
the Salmonella core genome. Mol. Microbiol., 66, 1174–1191.
7. Romby,P., Vandenesch,F. and Wagner,E.G.H. (2006) The role of
RNAs in the regulation of virulence-gene expression. Curr. Opin.
Microbiol., 9, 229–236.
8. Toledo-Arana,A., Dussurget,O., Nikitas,G., Sesto,N.,
Guet-Revillet,H., Balestrino,D., Loh,E., Gripenland,J., Tiensuu,T.,
Vaitkevicius,K. et al. (2009) The Listeria transcriptional landscape
from saprophytism to virulence. Nature, 18, 950–956.
9. Sharma,C.M., Hoffmann,S., Darfeuille,F., Reignier,J., Findeiss,S.,
Sittka,A., Chabas,S., Reiche,K., Hackermu ¨ ller,J., Reinhardt,R.
et al. (2010) The primary transcriptome of the major human
pathogen Helicobacter pylori. Nature, 464, 250–255.
10. Lorentz,C., Gesell,T., Zimmermann,B., Schoeberl,U., Bilusic,I.,
Rajkowitsch,L., Waldsich,C., von Haeseler,A. and Schroeder,R.
(2010) Genomix SELEX for Hfq binding RNAs identiﬁes
genomic aptamers predominantly in antisense transcripts.
Nucleic Acids Res., 38, 3794–3808.
11. Thomason,M.K. and Storz,G. (2010) Bacterial antisense RNAs:
how many are there, and what are they doing? Annu. Rev. Genet.,
44, 167–188.
12. Kawano,M., Aravind,L. and Storz,G. (2007) An antisense RNA
controls synthesis of an SOS-induced toxin evolved from an
antitoxin. Mol. Microbiol., 64, 738–754.
13. Du ¨ hring,U., Axmann,I.M., Hess,W. and Wilde,A. (2008) An
internal antisense RNA regulates expression of the photosynthesis
gene isiA. Proc. Natl. Acad. Sci. USA., 103, 7054–7058.
14. Pichon,C. and Felden,B. (2008) Small RNA genes identiﬁcations
and mRNA targets predictions in Bacteria. Bioinformatics, 24,
2807–2813.
15. Argaman,L., Hershberg,R., Vogel,J., Bejerano,G., Wagner,E.G.H.,
Margalit,H. and Altuvia,S. (2001) Novel small RNA-encoding
genes in the intergenic regions of Escherichia coli. Curr. Biol., 11,
941–950.
16. Rivas,E., Klein,R.J., Jones,T.A. and Eddy,S.R. (2001)
Computational identiﬁcation of noncoding RNAs in E. coli
by comparative genomics. Curr. Biol., 11, 1369–1373.
17. Pichon,C. and Felden,B. (2003) Intergenic Sequence Inspector:
searching and identifying bacterial RNAs. Bioinformatics, 19,
1707–1709.
18. Axmann,I., Kensche,P., Vogel,J., Kohl,S., Herzel,H. and Hess,W.
(2005) Identiﬁcation of cyanobacterial non-coding RNAs by
comparative genome analysis. Genome Biol., 6, R73.
Nucleic Acids Research,2012, Vol.40, No. 7 285919. Livny,J., Fogel,M.A., Davis,B.M. and Waldor,M.K. (2005)
sRNAPredict: an integrative computational approach to identify
sRNAs in bacterial genomes. Nucleic Acids Res., 33, 4096–4105.
20. Carter,R., Dubchak,I. and Holbrook,S. (2001) A computational
approach to identify genes for functional RNAs in genomic
sequences. Nucleic Acids Res., 29, 3928–3938.
21. Schattner,P. (2002) Searching for RNA genes using base
composition statistics. Nucleic Acids Res., 30, 2076–2082.
22. Saetrom,P., Sneve,R., Kristiansen,K.I., Snove,O., Gru ¨ nfeld,T.,
Rognes,T. and Seeberg,E. (2005) Predicting non-coding RNA
genes in Escherichia coli with boosted genetic programming.
Nucleic Acids Res., 33, 3263–3270.
23. Yachie,N., Numata,K., Saito,R., Kanai,A. and Tomita,M. (2006)
Prediction of non-coding and antisense RNA genes in Escherichia
coli with Gapped Markov Model. Gene, 372, 171–181.
24. Wang,C., Ding,C., Meraz,R. and Holbrook,S. (2006) PSoL: a
positive sample only learning algorithm for ﬁnding non-coding
RNA genes. Bioinformatics, 22, 2590–2596.
25. Uzilov,A., Keegan,J. and Mathews,D. (2006) Detection of
non-coding RNAs on the basis of predicted secondary structure
formation free energy change. BMC Bioinformatics, 7, 173–203.
26. Macke,T.J., Ecker,D.J., Gutell,R.R., Gautheret,D., Case,D.A. and
Sampath,R. (2001) RNAMotif, an RNA secondary structure
deﬁnition and search algorithm. Nucleic Acids Res., 29,
4724–4735.
27. Lesnik,E.A., Sampath,R., Levene,H.B., Henderson,T.J.,
McNeil,J.A. and Ecker,D.J. (2001) Prediction of rho-independent
transcriptional terminators in Escherichia coli. Nucleic Acids Res.,
29, 3583–3594.
28. Le Nove ` re,N. (2001) MELTING, computing the melting
temperature of nucleic acid duplex. Bioinformatics, 17, 1226–1227.
29. Kingsford,C., Ayandale,K. and Salsberg,S.L. (2007) Rapid,
accurate, computational discovery of Rho-independent
transcription terminators illuminates their relationship to DNA
uptake. Genome Biol., 8, R22.
30. Lalioui,L. and Le Bougue ´ nec,C. (2001) The afa-8 gene cluster is
carried by a pathogenicity island inserted into the tRNAPhe of
human and bovine pathogenic Escherichia coli isolates. Infect.
Immun., 69, 937–948.
31. Berger,H., Hacker,J., Juarez,A., Hughes,C. and Goebel,W. (1982)
Cloning of the chromosomal determinants encoding haemolysin
production and mannose resistant haemagglutination in
Escherichia coli. J. Bacteriol., 152, 1241–1247.
32. Holden,N.J., Totsika,M., Mahler,E., Roe,A.J., Catherwood,K.,
Lindner,K., Dobrindt,U. and Gally,D.L. (2006) Demonstration of
regulatory cross-talk between P ﬁmbriae and type 1 ﬁmbriae in
uropathogenic Escherichia coli. Microbiology, 152, 1143–1153.
33. Glaser,P., Rusniok,C., Chevalier,F., Buchrieser,C., Frangeul,L.,
Zouine,M., Couve,E., Lalioui,L., Msadek,T., Poyart,C. et al.
(2002) Genome sequence of Streptococcus agalactiae, a pathogen
causing invasive neonatal disease. Mol. Microbiol., 45, 1499–1513.
34. Urban,J.H. and Vogel,J. (2007) Translational control and target
recognition by Escherichia coli small RNAs in vivo. Nucleic Acids
Res., 35, 1018–1037.
35. Cherepanov,P.P. and Wackernagel,W. (1995) Gene disruption in
Escherichia coli: TcR and KmR cassette with the option of
Flp-catalyzed excision of the antibiotic resistance determinant.
Gene, 158, 9–14.
36. Chaveroche,M.K., Ghigo,J.M. and d’Enfert,C. (2000) A rapid
method for efﬁcient gene replacement in the ﬁlamentous fungus
Aspergillus nidulans. Nucleic Acids Res., 28, e97.
37. Lutz,R. and Bujard,H. (1997) Independent and tight regulation of
transcriptional units in Escherichia coli via the LacR/O, The
TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res.,
25, 1203–1210.
38. Datsenko,K.A. and Wanner,B.L. (2000) One-step inactivation of
chromosomal genes in Escherichia coli K-12 using PCR products.
Proc. Natl. Acad. Sci. USA, 97, 6640–6645.
39. Antal,M., Bordeau,V., Douchin,V. and Felden,B. (2005) A small
bacterial RNA regulates a putative ABC transporter. J. Biol.
Chem., 280, 7901–7908.
40. Livak,K.J. and Schmittgen,T.D. (2001) Analysis of relative gene
expression data using real-time quantitative PCR and the 2(-Delta
Delta C(T)) method. Methods, 25, 402–408.
41. Pichon,C., He ´ chard,C., du Merle,L., Chaudray,C., Bonne,I.,
Guadagnini,S., Vandewalle,A. and Le Bougue ´ nec,C. (2009)
Uropathogenic Escherichia coli AL511 requires ﬂagellum to enter
renal collecting duct cells. Cell. Microbiol., 11, 616–628.
42. Schrembri,M.A. and Klemm,P. (2001) Bioﬁlm formation in a
hydrodynamic environment by novel ﬁmH variants and
ramiﬁcations for virulence. Infect. Immun., 69, 1322–1328.
43. Pearson,W.R. (2000) Flexible sequence similarity searching with
the FASTA3 program package. Methods Mol. Biol., 132, 185–219.
44. Mathews,D.H., Sabina,J., Zuker,M. and Turner,D.H. (1999)
Expanded sequence dependence of thermodynamic parameters
improves prediction of RNA secondary structure. J. Mol. Biol.,
288, 911–940.
45. Delcher,A., Harmon,D., Kasif,S., White,O. and Salzberg,S. (1999)
Improved microbial gene identiﬁcation with GLIMMER.
Nucleic Acids Res., 27, 4636–4641.
46. Tjaden,B., Saxena,R.M., Stolyar,S., Haynor,D., Kolker,E. and
Rosenow,C. (2002) Transcriptome analysis of Escherichia coli
using high-density oligonucleotide probe arrays. Nucleic Acids
Res., 30, 3732–3738.
47. Raghavan,R., Groisman,E.A. and Ochman,H. (2011)
Genome-wide detection of novel regulatory RNAs in E. coli.
Genome Res, 21, 1487–1497.
48. Beaume,M., Hernandez,D., Farinelli,L., Deluen,C., Linder,P.,
Gaspin,C., Romby,P., Screnzel,J. and Francois,P. (2010)
Cartography of methicillin-resistant S. aureus transcripts:
detection, orientation and temporal expression during growth
phase and stress conditions. PLoS One, 5, e10725.
49. Touchon,M., Hoede,C., Tenaillon,O., Barbe,V., Baeriswyl,S.,
Bidet,P., Bingen,E., Bonacorsi,S., Bouchier,C., Bouvet,O. et al.
(2009) Organised genome dynamics in the Escherichia coli species:
the path to adaptation. PLoS Genetics, 5, e1000344.
50. Kaper,J.B., Nataro,J.P. and Mobley,H.L. (2004) Pathogenic
Escherichia coli. Nat. Rev. Microbiol., 2, 123–140.
51. Chen,S.L., Hung,C.S., Xu,J., Reigstad,C.S., Magrini,V., Sabo,A.,
Blasiar,D., Bieri,T., Meyer,R.R., Ozersky,P. et al. (2006)
Identiﬁcation of genes subject to positive selection in
uropathogenic strains of Escherichia coli: a comparative genomics
approach. Proc. Natl. Acad. Sci. USA, 103, 5977–5982.
52. Hochhut,B., Wilde,C., Balling,G., Middendorf,B., Dobrindt,U.,
Brzuszkiewicz,E., Gottschalk,G., Carniel,E. and Hacker,J. (2006)
Role of pathogenicity island-associated integrases in the genome
plasticity of uropathogenic Escherichia coli strain 536.
Mol. Microbiol., 61, 584–595.
53. Goode,T., Ho,W.Z., O’Connor,T., Busteed,S., Douglas,S.D.,
Shanahan,F. and O’Connell,J. (2002) Nested RT-PCR.
In: O’Connell,J. (ed.), Methods in Molecular Biology, RT-PCR
Protocols. Humana Press.
54. Wright,K.J., Seed,P.C. and Hultgren,S.J. (2007) Development of
intracellular bacterial communities of uropathogenic Escherichia
coli depends on type 1 pili. Cell. Microbiol., 9, 2230–2241.
55. Pratt,L. and Kolter,R. (1998) Genetic analysis of Escherichia coli
bioﬁlm formation: roles of ﬂagella, motility, chemotaxis and type
1 pili. Mol. Microbiol., 30, 285–293.
56. Raivio,T. (2005) Envelope stress responses and Gram-negative
bacterial pathogenesis. Mol. Microbiol., 56, 1119–1128.
57. Kulesus,R., Diaz-Perez,K., Slechta,S., Eto,D.S. and Mulvey,M.A.
(2008) Impact of the RNA chaperone Hfq on the ﬁtness and
virulence potential of uropathogenic Escherichia coli. Infect.
Immun., 76, 3019–3026.
58. Poyart,C., Re ´ glier-Poupet,H., Tazi,A., Billoe ¨ t,A., Dmytruk,N.,
Bidet,P., Bingen,E., Raymond,J. and Trieu-Cuot,P. (2008)
Invasive group B streptococcal infections in infants, France.
Emerg. Infect. Dis., 14, 1647–1649.
59. Marx,P., Nuhn,M., Kovacs,M., Hakenbeck,R. and Bru ¨ ckner,R.
(2010) Identiﬁcation of genes for small non-coding RNAs that
belongs to the regulon of the two component regulatory system
CiaRH in Streptococcus. BMC Genomics, 11, e661.
60. Brodeur,B., Boyer,M., Charlebois,I., Hamel,J., Couture,F.,
Rioux,C. and Martin,D. (2000) Identiﬁcation of group B
streptococcal Sip protein, which elicits cross protective immunity.
Infect. Immun., 68, 5610–5618.
61. Mendoza-Vargas,A., Olvera,L., Olvera,M., Grande,R.,
Vega-Alvarado,L., Taboada,B., Jimenez-Jacinto,V., Salgado,H.,
2860 Nucleic Acids Research, 2012,Vol.40, No. 7Juarez,K., Contreras-Moreira,B. et al. (2009) Genome-wide
identiﬁcation of transcription start sites, promoters and
transcription factor binding sites in E. coli. PLoS ONE, 4, e7526.
62. Chinni,S.V., Raabe,C.A., Zakaria,R., Randau,G., Hock Hoe,C.,
Zemann,A., Brosius,J., Tang,T.H. and Rozhdestvensky,T.S. (2010)
Experimental identiﬁcation and characterization of 97 novel
npcRNA candidates in Salmonella enterica serovar Typhi.
Nucleic Acids Res., 38, 5893–5908.
63. Novick,R.P., Ross,H.F., Projan,S.J., Kornblum,J., Kreiswirth,B.
and Moghazeh,S. (1993) Synthesis of staphylococcal virulence
factors is controlled by a regulatory RNA molecule. EMBO J.,
12, 3967–3975.
64. Chabelskaya,S., Gaillot,O. and Felden,B. (2010) A Staphylococcus
aureus small RNA is required for bacterial virulence and regulates
the expression of an immune-evasion molecule. PLoS Pathog., 6,
e1000927.
65. Klenk,M., Koczan,D., Guthke,R., Nakata,M., Thiesen,H.J.,
Podbielski,A. and Kreikenmeyer,B. (2005) Global epithelial cell
transcriptional responses reveal Streptococcus pyogenes Fas
regulator activity association with bacterial aggressiveness.
Cell. Microbiol., 7, 1237–1250.
66. Lee,E.J. and Groisman,E.A. (2010) An antisense RNA that
governs the expression kinetics of a multifunctional virulence
gene. Mol. Microbiol., 76, 1020–1033.
67. Podkaminski,D. and Vogel,J. (2010) Small RNAs promote
mRNA stability to activate the synthesis of virulence factors.
Mol. Microbiol., 78, 1327–1331.
68. Halfmann,A., Kovacs,M., Hakenbeck,R. and Bru ¨ ckner,R. (2007)
Identiﬁcation of the genes directly controlled by the response
regulator CiaR in Streptococcus pneumoniae: ﬁve out of 15
promoters drive expression of small non-coding RNAs. Mol.
Microbiol., 66, 110–126.
69. Perez,N., Trevino,J., Liu,Z., Ho,S.C.M., Babitzke,P. and
Sumby,P. (2009) A genome-wide analysis of small regulatory
RNAs in the human pathogen group A Streptococcus. PLOS
One, 4, e7668.
70. Brown,S. and Fournier,M.J. (1984) The 4.5 S RNA gene of
Escherichia coli is essential for cell growth. J. Mol. Biol., 178,
533–550.
71. Brownlee,G.G. (1971) Sequence of 6S RNA of E. coli. Nature
New Biol., 229, 147–149.
72. Okamoto,K. and Freundlich,M. (1986) Mechanism for the
autogenous control of the crp operon: Transcriptional inhibition
by a divergent RNA transcript. Proc. Natl. Acad. Sci. USA, 83,
5000–5004.
73. Liu,M.Y., Gui,G., Wei,B., Preston,J.F., Oakford,L., Yuksel,U.,
Giedroc,D.P. and Romeo,T. (1997) The RNA molecule CsrB
binds to the global regulatory protein CsrA and antagonizes its
activity in Escherichia coli. J. Biol. Chem., 272, 17502–17510.
74. Wassarman,K., Repoila,F., Rosenow,C., Storz,G. and
Gottesman,S. (2001) Identiﬁcation of novel small RNAs using
comparative genomics and microarrays. Genes & Dev., 15,
1637–1651.
75. Tetart,F. and Bouche,J.P. (1992) Regulation of the expression of
the cell cycle gene ftsZ by DicF antisense RNA. Division does
not require a ﬁxed number of FtsZ molecules. Mol. Microbiol., 6,
615–620.
76. Sledjeski,D. and Gottesman,S. (1995) A small RNA acts as an
antisilencer of the H-NS-silenced rcsA gene of Escherichia coli.
Proc. Natl. Acad. Sci. USA, 92, 2003–2007.
77. Chen,S., Lesnik,E.A., Hall,T.A., Sampath,R., Griffrey,R.H.,
Ecker,D.J. and Blyn,L.B. (2002) A bioinformatics based approach
to discover small RNA genes in the Escherichia coli genome.
BioSystems, 65, 157–177.
78. Urbanowski,M.L., Stauffer,L.T. and Stauffer,G.V. (2000) The
gcvB gene encodes a small untranslated RNA involved in
expression of the dipeptide and oligopeptide transport systems in
Escherichia coli. Mol. Microbiol., 37, 856–868.
79. Rivas,E. and Eddy,S.R. (2001) Noncoding RNA gene detection
using comparative sequence analysis. BMC Bioinformatics, 2,
1–19.
80. Cole,S.T. and Honore,N. (1989) Transcription of the sulA-ompA
region of Escherichia coli during the SOS response and the role
of an antisense RNA molecule. Mol. Microbiol., 3, 715–722.
81. Vogel,J., Argaman,L., Wagner,E.G.H. and Altuvia,S. (2004)
The Small RNA IstR Inhibits Synthesis of an SOS-Induced Toxic
Peptide. Curr. Biol., 14, 2271–2276.
82. Jain,S.K., Gurevitz,M. and Apirion,D. (1982) A small RNA that
complements mutants in the RNA processing enzyme ribonuclease
P. J. Mol. Biol., 162, 515–533.
83. Mizuno,T., Chou,M.Y. and Inouye,M. (1984) A unique
mechanism regulating gene expression: translational inhibition by
a complementary RNA transcript (micRNA). Proc. Natl. Acad.
Sci., 81, 1966–1970.
84. Argaman,L. and Altuvia,S. (2000) fhlA repression by OxyS
RNA: kissing complex formation at two sites results in a
stable antisense-target RNA complex. J. Mol. Biol., 300,
1101–1112.
85. Kawano,M., Oshima,T., Kasai,H. and Mori,H. (2002) Molecular
characterization of long direct repeat (LDR) sequences expressing
a stable mRNA encoding for a 35-amino-acid cell-killing peptide
and a cis-encoded small antisense RNA in Escherichia coli. Mol.
Microbiol., 45, 333–349.
86. Majdalani,N., Chen,S., Murrow,J., St John,K. and Gottesman,S.
(2001) Regulation of RpoS by a novel small RNA: the
characterization of RprA. Mol. Microbiol., 39, 1382–1394.
87. Douchin,V., Bohn,C. and Bouloc,P. (2006) Down-regulation
of porins by a small RNA bypasses the essentiality of the RIP
protease RseP in Escherichia coli. J. Biol. Chem., 281,
12253–12256.
88. Bosl,M. and Kersten,H. (1991) A novel RNA product of the tyrT
operon of Escherichia coli. Nucleic Acids Res., 19, 5863–5870.
89. Zhang,A., Wassarman,K.M., Rosenow,C., Tjaden,B.C., Storz,G.
and Gottesman,S. (2003) Global analysis of small RNA and
mRNA targets of Hfq. Mol. Microbiol., 50, 1111–1124.
90. Kawano,M., Reynolds,A., Miranda-Rios,J. and Storz,G. (2005)
Detection of 50- and 30-UTR-derived small RNAs and cis-encoded
antisense RNAs in Escherichia coli. Nucleic Acids Res, 33,
1040–1050.
91. Polayes,D.A., Rice,P.W. and Dahlberg,J.E. (1988) DNA
polymerase I activity in Escherichia coli is inﬂuenced by spot
42 RNA. J. Bacteriol., 170, 2083–2088.
92. Vogel,J., Bartels,V., Tang,T.H., Churakov,G., Slagter-Jager,J.,
Huttenhofer,A. and Wagner,E.G.H. (2003) RNomics in
Escherichia coli detects new sRNA species and indicates parallel
transcriptional output in bacteria. Nucleic Acids Res, 31,
6435–6443.
93. Keiler,K.C., Waller,P.R. and Sauer,R.T. (1996) Role of a peptide
tagging system in degradation of proteins synthesized from
damaged messenger RNA. Science, 271, 990–993.
94. Geissman,T., Chevalier,C., Cros,M.J., Boisset,S., Fechter,P.,
Noirot,C., Schrenzel,J., Franc ¸ ois,P., Vandenesch,F., Gaspin,C.
et al. (2009) A search for small noncoding RNAs in
Staphylococcus aureus reveals a conserved sequence motif for
regulation. Nucleic Acids Res., 37, 7239–7257.
95. Marchais,A., Naville,M., Bohn,C., Bouloc,P. and Gautheret,D.
(2009) Single-pass classiﬁcation of all non-coding sequences in
a bacterial genome using phylogenetic proﬁles. Genome Res., 19,
1084–1092.
96. Bohn,C., Rigoulay,C., Chabelskaya,S., Sharma,C.M.,
Marchais,A., Skorski,P., Boreze ´ e-Durant,E., Barbet,R.,
Jacquet,E., Jacq,A. et al. (2010) Experimental discovery of small
RNAs in Staphylococcus aureus reveals a riboregulator of central
metabolism. Nucleic Acids Res., 38, 6620–6636.
97. Abu-Qatouseh,L.F., Chinni,S.V., Seggewiss,J., Proctor,R.A.,
Brosius,J., Roshdestvensky,T.S., Peters,G., von Eiff,C. and
Becker,K. (2010) Identiﬁcation of differentially expressed small
non-protein-coding RNAs in Staphylococcus aureus displaying
both the normal and the small-colony variant phenotype.
J. Mol. Med., 88, 565–575.
Nucleic Acids Research,2012, Vol.40, No. 7 2861